Literature DB >> 24808541

Phosphate overload directly induces systemic inflammation and malnutrition as well as vascular calcification in uremia.

Shunsuke Yamada1, Masanori Tokumoto2, Narihito Tatsumoto3, Masatomo Taniguchi3, Hideko Noguchi3, Toshiaki Nakano3, Kosuke Masutani3, Hiroaki Ooboshi2, Kazuhiko Tsuruya4, Takanari Kitazono3.   

Abstract

Hyperphosphatemia contributes to increased cardiovascular mortality through vascular calcification (VC) in patients with chronic kidney disease (CKD). Malnutrition and inflammation are also closely linked to an increased risk of cardiovascular death in CKD. However, the effects of Pi overload on inflammation and malnutrition remain to be elucidated. The aim of the present study was to investigate the effects of dietary Pi loading on the interactions among inflammation, malnutrition, and VC in CKD. We used control rats fed normal diets and adenine-induced CKD rats fed diets with different Pi concentrations ranging from 0.3% to 1.2% for 8 wk. CKD rats showed dietary Pi concentration-dependent increases in serum and tissue levels of TNF-α and urinary and tissue levels of oxidative stress markers and developed malnutrition (decrease in body weight, serum albumin, and urinary creatinine excretion), VC, and premature death without affecting kidney function. Treatment with 6% lanthanum carbonate blunted almost all changes induced by Pi overload. Regression analysis showed that serum Pi levels closely correlated with the extent of inflammation, malnutrition, and VC. Also, in cultured human vascular smooth muscle cells, high-Pi medium directly increased the expression of TNF-α in advance of the increase in osteochondrogenic markers. Our data suggest that dietary Pi overload induces systemic inflammation and malnutrition, accompanied by VC and premature death in CKD, and that inhibition of Pi loading through dietary or pharmacological interventions or anti-inflammatory therapy may be a promising treatment for the prevention of malnutrition-inflammation-atherosclerosis syndrome.
Copyright © 2014 the American Physiological Society.

Entities:  

Keywords:  chronic kidney disease; inflammation; malnutrition; malnutrition-inflammation-atherosclerosis syndrome; phosphate; vascular calcification

Mesh:

Substances:

Year:  2014        PMID: 24808541     DOI: 10.1152/ajprenal.00633.2013

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  53 in total

Review 1.  Vitamin D, cancer, and dysregulated phosphate metabolism.

Authors:  Ronald B Brown
Journal:  Endocrine       Date:  2019-06-23       Impact factor: 3.633

Review 2.  Ironing out the cross talk between FGF23 and inflammation.

Authors:  Valentin David; Connor Francis; Jodie L Babitt
Journal:  Am J Physiol Renal Physiol       Date:  2016-08-31

3.  Association of Parameters of Mineral Bone Disorder with Mortality in Patients on Hemodialysis according to Level of Residual Kidney Function.

Authors:  Mengjing Wang; Yoshitsugu Obi; Elani Streja; Connie M Rhee; Wei Ling Lau; Jing Chen; Chuanming Hao; Takayuki Hamano; Csaba P Kovesdy; Kamyar Kalantar-Zadeh
Journal:  Clin J Am Soc Nephrol       Date:  2017-05-09       Impact factor: 8.237

4.  Coronary risk score for mineral bone disease in chronic non-diabetic hemodialysis patients: results from a prospective pilot study.

Authors:  Cristiana David; Jordi Bover; Cornelia Voiculet; Ileana Peride; Lucian Cristian Petcu; Andrei Niculae; Adrian Covic; Ionel Alexandru Checherita
Journal:  Int Urol Nephrol       Date:  2016-12-18       Impact factor: 2.370

Review 5.  Latest consensus and update on protein-energy wasting in chronic kidney disease.

Authors:  Yoshitsugu Obi; Hemn Qader; Csaba P Kovesdy; Kamyar Kalantar-Zadeh
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2015-05       Impact factor: 4.294

Review 6.  Inflammation regulates fibroblast growth factor 23 production.

Authors:  Connor Francis; Valentin David
Journal:  Curr Opin Nephrol Hypertens       Date:  2016-07       Impact factor: 2.894

7.  Activation of the mTORC1 pathway by inflammation contributes to vascular calcification in patients with end-stage renal disease.

Authors:  Jing Liu; Wei Zhu; Chun Ming Jiang; Yuan Feng; Yang Yang Xia; Qing Yan Zhang; Miao Zhang
Journal:  J Nephrol       Date:  2018-05-14       Impact factor: 3.902

8.  αKlotho Mitigates Progression of AKI to CKD through Activation of Autophagy.

Authors:  Mingjun Shi; Brianna Flores; Nancy Gillings; Ao Bian; Han Jun Cho; Shirley Yan; Yang Liu; Beth Levine; Orson W Moe; Ming Chang Hu
Journal:  J Am Soc Nephrol       Date:  2015-12-23       Impact factor: 10.121

Review 9.  Alpha Klotho and phosphate homeostasis.

Authors:  A Bian; C Xing; M C Hu
Journal:  J Endocrinol Invest       Date:  2014-09-07       Impact factor: 4.256

10.  Blood pressure and phosphate level in diabetic and non-diabetic kidney disease: Results of the cross-sectional "Low Clearance Consultation" study.

Authors:  Margarida Mendes; Luis Resende; Alves Teixeira; João Correia; Gil Silva
Journal:  Porto Biomed J       Date:  2017-03-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.